(Q83434939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Nathalie Gachard

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Norbert Ifrah

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Noel Jean Milpied

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

P Chevallier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M Labopin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

P Turlure

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A Pigneux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M Hunault

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

K Filanovsky

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

P Cornillet-Lefebvre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

I Luquet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

L Lode

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

S Richebourg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

O Blanchet

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

N Vey

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J-L Harousseau

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M-C Bene

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M Mohty

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J Delaunay

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

18 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

939-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331073%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.25

22 January 2020

exact match

0 references

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Guidelines on the management of acute myeloid leukaemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Prognostic index for adult patients with acute myeloid leukemia in first relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Biology and management of relapsed acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Advantage of MIDAM protocol in treatment of elderly patients with refractory and relapsing acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 tri

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Gemtuzumab ozogamicin: is there room for salvage?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.25

7 January 2021